ACM
BMRN icon

Asymmetry Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Asymmetry Capital Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$15.7M Buy
+177,741
New +$14.7M 8.34% 1
2021
Q1 		– Sell
-88,195
Closed -$7.73M – 30
2020
Q4 		$7.73M Buy
+88,195
New +$6.99M 3.53% 12
2020
Q2 		– Sell
-54,676
Closed -$4.62M – 34
2020
Q1 		$4.62M Buy
54,676
+20,895
+62% +$1.8M 5.05% 5
2019
Q4 		$2.86M Sell
33,781
-15,481
-31% -$1.17M 5.12% 2
2019
Q3 		$3.32M Sell
49,262
-127,063
-72% -$9.79M 7.12% 6
2019
Q2 		$15.1M Buy
+176,325
New +$15.1M 8.18% 3
2018
Q1 		– Sell
-10,733
Closed -$957K – 37
2017
Q4 		$957K Buy
+10,733
New +$933K 1.3% 22

Other funds holding BMRN

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return